Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER EPIGENETICS

A role for chromatin regulatory dynamics in breast cancer evolution

Nature Medicine volume 24, pages 1309–1311 (2018)Cite this article

Subjects

Enhancer profiling of breast tumors reveals that chromatin regulatory elements contribute to the clonal fitness landscape, treatment resistance and phenotypic divergence.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Active enhancers are linked to breast cancer heterogeneity and drug resistance.

References

  1. Cancer Genome Atlas Network. Nature 490, 61–70 (2012).

    Google Scholar 

  2. Curtis, C. et al. Nature 486, 346–352 (2012).

    Article  CAS  Google Scholar 

  3. Patten, D. K. Nat. Med. https://doi.org/10.1038/s41591-018-0091-x (2018).

  4. Pogrebniak, K. L. & Curtis, C. Trends Genet. 34, 639–651 (2018).

    Article  CAS  Google Scholar 

  5. Dulken, B. W., Leeman, D. S., Boutet, S. C., Hebestreit, K. & Brunet, A. Cell Reports 18, 777–790 (2017).

    Article  CAS  Google Scholar 

  6. Chen, H. et al. Cell 173, 386–399.e12 (2018).

    Article  CAS  Google Scholar 

  7. Yates, L. R. et al. Nat. Med. 21, 751–759 (2015).

    Article  CAS  Google Scholar 

  8. Weintraub, A. S. et al. Cell 171, 1573–1588 (2017).

    Article  CAS  Google Scholar 

  9. He, Y. et al. Neuron 55, 217–230 (2007).

    Article  CAS  Google Scholar 

  10. Osborne, C. K. & Schiff, R. Annu. Rev. Med. 62, 233–247 (2011).

    Article  CAS  Google Scholar 

  11. Azizi, E. et al. Cell https://doi.org/10.1016/j.cell.2018.05.060 (2018).

Download references

Author information

Authors and Affiliations

  1. Department of Genetics, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, CA, USA

    Christopher Probert & Christina Curtis

  2. Department of Medicine, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, CA, USA

    Christina Curtis

Authors
  1. Christopher Probert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christina Curtis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christina Curtis.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Probert, C., Curtis, C. A role for chromatin regulatory dynamics in breast cancer evolution. Nat Med 24, 1309–1311 (2018). https://doi.org/10.1038/s41591-018-0182-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-018-0182-8

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer